Showing results (11-20 of 176) with videos related to
Sort By:
Pageof 18
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 13, 2009
Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?Juan Torras, Immaculada Herrero-Fresneda, Oscar Gulias, et al.Clinical Kidney Journal|June 23, 2017
Looking for the needle in the kidney transplantation haystackJosep M Cruzado, Edoardo MelilliStem Cells and Development|April 13, 2012
Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft modelMarcella Franquesa, Esther Herrero, Joan Torras, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progressJosep M Grinyó, Josep M CruzadoContributions to Nephrology|November 30, 2004
Steroid or calcineurin inhibitor-sparing immunosuppressive protocolsJosep M Grinyó, Josep M CruzadoNephron|February 17, 2025
Subclinical Inflammation and Renal Allograft Dysfunction: Myth or Reality?Carlos Couceiro, Maria Visent, Josep M CruzadoInternational Journal of Molecular Sciences|February 15, 2022
Molecular Mechanisms of Kidney Injury and RepairSandra Rayego-Mateos, Laura Marquez-Expósito, Raquel Rodrigues-Diez, et al.Clinical Kidney Journal|October 30, 2020
Prediction scores for risk of allograft loss in patients receiving kidney transplants: nil satis nisi optimumNuria Montero, Sergi Codina, Josep M CruzadoClinical Kidney Journal|June 1, 2023
Searching in the maze: sodium-glucose cotransporter-2 inhibitors in kidney transplant recipients to improve survivalLaia Oliveras, Núria Montero, Josep M CruzadoTransplantation|April 23, 2009
Inhibitors of the mammalian target of rapamycin and transplant toleranceOriol Bestard, Josep M Cruzado, Josep M GrinyóPageof 18